ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

STX Shield Therapeutics Plc

1.75
0.00 (0.00%)
Last Updated: 08:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Shield Therapeutics Plc LSE:STX London Ordinary Share GB00BYV81293 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1.75 1.70 1.80 1.75 1.75 1.75 274,932 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 4.47M -40.44M -0.0522 -0.34 13.57M
Shield Therapeutics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker STX. The last closing price for Shield Therapeutics was 1.75p. Over the last year, Shield Therapeutics shares have traded in a share price range of 1.075p to 12.75p.

Shield Therapeutics currently has 775,429,360 shares in issue. The market capitalisation of Shield Therapeutics is £13.57 million. Shield Therapeutics has a price to earnings ratio (PE ratio) of -0.34.

Shield Therapeutics Share Discussion Threads

Showing 3426 to 3449 of 23475 messages
Chat Pages: Latest  147  146  145  144  143  142  141  140  139  138  137  136  Older
DateSubjectAuthorDiscuss
17/6/2019
09:52
Tick tock to 27 July, looking for another opportunity to top up here.
Took a stake in (C4XD) recently, rising on a telegraph write up, let’s hope it follows this share price chart!

ny boy
13/6/2019
12:39
Not sure if any of the regulars are going, no doubt we will hear more later.
ny boy
13/6/2019
11:34
Be interested in comments on what’s coming out of the Norgine sales effort in Germany. 6 months of effort should have yielded something.
crankyman
13/6/2019
11:31
No idea, haven’t heard anything, says on their web site it’s over 2 days 13-14 June?
ny boy
13/6/2019
08:10
NY do you think anything might come out of today's agm, ?
wuzy
13/6/2019
07:55
FDA decision fast closing in... only 32 trading days to go!
ny boy
11/6/2019
22:31
Slow grind higher, anyone that wanted to cash in has probably already done so! Should get a bit perky last week or so before FDA decision
ny boy
11/6/2019
21:05
From the chart it looks like the rise has stalled temporarily. I hope I am wrong but anyway I am sure normal service will be resumed shortly
nobbygnome
11/6/2019
20:53
You are probably correct Montyhedge but I still think this is a very conservative view. Pharma shares with this IP must eventually be around 1000p. It might take a year but if they can fight off a buy out I am sure that the potential of the product to dominate the US and China market must be massive. My guess is the current graph profile will continue. Onwards and upwards. My £20k initial investmentlooks good.
maximus72
11/6/2019
20:48
>> az4hr

I know nothing about either of the companies. Sorry.

nobbygnome
11/6/2019
15:21
Monty was that your sell... 8 shares @ 115p? 😁
ny boy
11/6/2019
11:41
az4hr

I bought a few C4XD today, early days but a decent pull back. Don’t know about the other stock.

Tick tick here to 27 July

ny boy
11/6/2019
10:08
150p before 27th July should have a run up, seems deals all lined up, if approved, the US the biggest market, to me it's a given, I see 275p if not I see 85p. That's my view.
montyhedge
11/6/2019
09:03
Should trade in a 110-150p trading range me thinks.

I guess any spike closer to 27 July may suggest rumors of a leak

ny boy
10/6/2019
23:27
Nobby have you looked at 4d pharma or c4xd do you have any opinions on them two
thanks
azhar

az4hr
10/6/2019
21:11
I agree. If the deal is similar to the Norgine deal (or better), then surely it will be cheaper for the licensee to take STX out especially if the price is still languishing below £2. This includes taking into account the royalties they will pay over the next ten years.
nobbygnome
10/6/2019
21:07
I personally would not worry to much about pricing in other European countries because if we get the right FDA result this company will get taken out.
I just can’t see it not happening it’s just a case of who is bidding which will dictate The premium but minimum 3-4times current valuation.

best1467
10/6/2019
19:07
Peel Hunt restated their buy rating on shares of Shield Therapeutics (LON:STX) in a research report sent to investors on Monday, June 3rd, ThisIsMoney.Co.Uk reports.
A number of other research analysts have also recently commented on STX. Liberum Capital reaffirmed a buy rating on shares of Shield Therapeutics in a research report on Monday, March 4th. FinnCap initiated coverage on Shield Therapeutics in a research report on Tuesday, May 14th. They set a corporate rating and a GBX 200 ($2.61) price target on the stock.

ny boy
10/6/2019
13:14
Good advice NYboy. These Gordon Gekko wannabes are getting mugged every time.
maximus72
10/6/2019
13:13
Took a few more
volsung
10/6/2019
09:20
Not long to go before take off.
montyhedge
10/6/2019
08:29
The Teva appeal is of no real consequence for the medium term. There is only any possible effect after 2029! There is loads of money to be made by Shield and their licensees before then.

I know the market discounts into the future..but not quite for 10 years!

nobbygnome
10/6/2019
08:24
Buy those mini dips Sir, rinse & repeat since 20p’s, each time PI’s have had their shares stolen from them 🤦🏻‍♂️🆙⬆5039;
ny boy
08/6/2019
11:55
The £1000 TEVA appeal.
peachie 74
Chat Pages: Latest  147  146  145  144  143  142  141  140  139  138  137  136  Older

Your Recent History

Delayed Upgrade Clock